RxDoctor Payments DataLook up a doctor →

Gina Bolinger, PA

Medical · Thornton, CONPI 1699849315

Payments from drug & device makers

$11,616in general payments, 2019–2025

Across 657 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$893
  • Boehringer Ingelheim$810
  • Bayer$469
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$11,53199%
  • Education$851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)165$2,424
Novo Nordisk58$1,136
AstraZeneca57$1,112
Lilly USA, LLC56$893
Boehringer Ingelheim52$810
Bayer23$469
Amgen(2 entities)23$433
GSK18$341
Pfizer19$323
Astellas Pharma US Inc10$313
Abbott15$283
Johnson & Johnson16$266
Novartis8$180
Medtronic7$177
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$163
Merck10$155
Sanofi-aventis U.S. LLC7$142
Biohaven Pharmaceutical Holding Company Ltd.7$142
Biohaven Pharmaceuticals, Inc.6$134
Takeda Pharmaceuticals U.S.A., Inc.7$133
Grifols USA, LLC6$124
Exact Sciences5$117
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$103
Genentech USA, Inc.5$88
Jazz Pharmaceuticals Inc.4$74
Amarin Pharma, Inc.4$65
Hologic Sales And Service, LLC3$65
Edwards Lifesciences2$54
Eisai Inc.3$51
Seqirus USA Inc2$49
Otsuka America Pharmaceutical, Inc.3$44
Idorsia Pharmaceuticals US Inc3$44
Currax Pharmaceuticals LLC3$44
E.r. Squibb & Sons, L.L.C.2$44
Organon2$41
Ultragenyx Pharmaceutical Inc.2$39
Lundbeck LLC2$39
Philips North America LLC1$35
Si-bone, Inc.2$34
Nestle Healthcare Nutrition Inc.2$33
Alfasigma USA, Inc.2$29
Abiomed1$28
Coopersurgical, Inc.2$27
Dexcom, Inc.1$24
Corium, LLC2$24
Esperion Therapeutics, Inc.1$24
Avanir Pharmaceuticals, Inc.1$24
Impulse Dynamics (USA) Inc.1$22
Boston Scientific1$22
IBSA Pharma Inc.1$21
Cequr Corporation1$20
Kyowa Kirin, Inc.1$18
Heartflow, Inc.1$17
Nevro Corp.1$17
Lucid Diagnostics Inc.1$16
C. R. Bard, Inc. & Subsidiaries1$16
Neurocrine Biosciences, Inc.1$15
Cranial Technologies, Inc1$15
Regeneron Healthcare Solutions, Inc.1$13
VBI Vaccine (delaware) Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,616 in reported general payments places this provider in the 95th percentile of 766 medical providers in Colorado.

See all medical providers in Colorado

Medicare billing

Part B allowed, 2024
$16,073
Medicare patients
72
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$45,676
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$31,299
XareltoRivaroxaban24$26,319
EliquisApixaban26$21,887
JardianceEmpagliflozin11$20,186
OzempicSemaglutide18$17,484
FarxigaDapagliflozin Propanediol15$15,410
LinzessLinaclotide19$13,601
Breztri AerosphereBudesonide/Glycopyr/Formoterol17$11,493
Spiriva RespimatTiotropium Bromide13$8,263
MovantikNaloxegol Oxalate13$7,919
Atrovent HfaIpratropium Bromide14$6,963
VyvanseLisdexamfetamine Dimesylate15$6,148
EntrestoSacubitril/Valsartan12$5,645
Fluticasone-SalmeterolFluticasone Propion/Salmeterol14$4,059

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$893$45,67621 claims
GSKTrelegy Ellipta$341$31,29931 claims
Boehringer IngelheimJardiance, Spiriva Respimat$810$28,44924 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,112$26,90332 claims
Johnson & JohnsonXarelto$266$26,31924 claims
PfizerEliquis$323$21,88726 claims
Novo NordiskOzempic$1,136$17,48418 claims
AbbVieLinzess$2,424$13,60119 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$133$6,14815 claims
NovartisEntresto$180$5,64512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 766 medical providers in Colorado.

Other medical in Thornton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →